Evidence map›Paper›PMID 33814617›Full record

ReviewMonatshefte fur chemie2021

Antimalarial and anticancer properties of artesunate and other artemisinins: current development.

Pitambar Khanal

Open access · bronzeAbstract readReview
In one paragraph

Review in Monatshefte fur chemie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Chemopreventive Potential of Artemisinin andInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Anti-tumor mechanism of artesunate.Frontiers in pharmacology · 2024
    Review
  13. The Effect ofIranian journal of biotechnology · 2024
    Article
  14. Proposition ofCombinatorial chemistry & high throughput screening · 2024
    Review
  15. Tropical medicine and infectious disease · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Pitambar KhanalNagarik College, Tribhuvan University, Gaidakot-2, Nawalparasi Purva, Gandaki, Nepal.ORCID 0000-0002-0454-2275
Tribhuvan University · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review provides a recent perspective of artesunate and other artemisinins as antimalarial drugs and their uses in cancer therapy. Artesunate is an artemisinin derivative. Artemisinin is extracted from the plant GRAPHIC ABSTRACT:

Indexed as

Anticancer drugAntimalarial drugArtemisininsPlasmodium falciparum

Identifiers

PMID33814617
PMCPMC8008344
OpenAlexW3148994527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.